Cargando…
Functional regulations between genetic alteration-driven genes and drug target genes acting as prognostic biomarkers in breast cancer
Differences in genetic molecular features including mutation, copy number alterations and DNA methylation, can explain interindividual variability in response to anti-cancer drugs in cancer patients. However, identifying genetic alteration-driven genes and characterizing their functional mechanisms...
Autores principales: | Wang, Li, Yu, Lei, Shi, Jian, Li, Feng, Zhang, Caiyu, Xu, Haotian, Yin, Xiangzhe, Wang, Lixia, Lin, Shihua, Litvinova, Anastasiia, Ping, Yanyan, Ning, Shangwei, Zhao, Hongying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226112/ https://www.ncbi.nlm.nih.gov/pubmed/35739271 http://dx.doi.org/10.1038/s41598-022-13835-5 |
Ejemplares similares
-
Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data
por: Zhao, Hongying, et al.
Publicado: (2022) -
LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA–target regulations in human diseases
por: Zhao, Hongying, et al.
Publicado: (2022) -
Comprehensive characterization of clonality of driver genes revealing their clinical relevance in colorectal cancer
por: Shi, Jian, et al.
Publicado: (2022) -
The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis
por: Wang, Li, et al.
Publicado: (2022) -
Integrated analysis of single-cell and bulk RNA sequencing data reveals immune-related lncRNA-mRNA prognostic signature in triple-negative breast cancer
por: Zhao, Hongying, et al.
Publicado: (2023)